BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25974391)

  • 1. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
    Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
    J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
    Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
    J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of small molecule inhibitors of BRPF1 and TRIM24 bromodomains.
    Palmer WS
    Drug Discov Today Technol; 2016 Mar; 19():65-71. PubMed ID: 27769360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
    Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
    J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
    Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
    Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network.
    Liu J; Li F; Bao H; Jiang Y; Zhang S; Ma R; Gao J; Wu J; Ruan K
    FEBS J; 2017 Apr; 284(7):1082-1095. PubMed ID: 28207202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "Gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.
    Unzue A; Zhao H; Lolli G; Dong J; Zhu J; Zechner M; Dolbois A; Caflisch A; Nevado C
    J Med Chem; 2016 Apr; 59(7):3087-97. PubMed ID: 26982797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
    Gechijian LN; Buckley DL; Lawlor MA; Reyes JM; Paulk J; Ott CJ; Winter GE; Erb MA; Scott TG; Xu M; Seo HS; Dhe-Paganon S; Kwiatkowski NP; Perry JA; Qi J; Gray NS; Bradner JE
    Nat Chem Biol; 2018 Apr; 14(4):405-412. PubMed ID: 29507391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based discovery of selective BRPF1 bromodomain inhibitors.
    Zhu J; Zhou C; Caflisch A
    Eur J Med Chem; 2018 Jul; 155():337-352. PubMed ID: 29902720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins.
    Igoe N; Bayle ED; Tallant C; Fedorov O; Meier JC; Savitsky P; Rogers C; Morias Y; Scholze S; Boyd H; Cunoosamy D; Andrews DM; Cheasty A; Brennan PE; Müller S; Knapp S; Fish PV
    J Med Chem; 2017 Aug; 60(16):6998-7011. PubMed ID: 28714688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
    Fedorov O; Lingard H; Wells C; Monteiro OP; Picaud S; Keates T; Yapp C; Philpott M; Martin SJ; Felletar I; Marsden BD; Filippakopoulos P; Müller S; Knapp S; Brennan PE
    J Med Chem; 2014 Jan; 57(2):462-76. PubMed ID: 24313754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Targeting of Bromodomains of the Bromodomain-PHD Fingers Family Impairs Osteoclast Differentiation.
    Meier JC; Tallant C; Fedorov O; Witwicka H; Hwang SY; van Stiphout RG; Lambert JP; Rogers C; Yapp C; Gerstenberger BS; Fedele V; Savitsky P; Heidenreich D; Daniels DL; Owen DR; Fish PV; Igoe NM; Bayle ED; Haendler B; Oppermann UCT; Buffa F; Brennan PE; Müller S; Gingras AC; Odgren PR; Birnbaum MJ; Knapp S
    ACS Chem Biol; 2017 Oct; 12(10):2619-2630. PubMed ID: 28849908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery.
    Zhan Y; Kost-Alimova M; Shi X; Leo E; Bardenhagen JP; Shepard HE; Appikonda S; Vangamudi B; Zhao S; Tieu TN; Jiang S; Heffernan TP; Marszalek JR; Toniatti C; Draetta G; Tyler J; Barton M; Jones P; Palmer WS; Geck Do MK; Andersen JN
    Epigenetics Chromatin; 2015; 8():37. PubMed ID: 26396593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
    Igoe N; Bayle ED; Fedorov O; Tallant C; Savitsky P; Rogers C; Owen DR; Deb G; Somervaille TC; Andrews DM; Jones N; Cheasty A; Ryder H; Brennan PE; Müller S; Knapp S; Fish PV
    J Med Chem; 2017 Jan; 60(2):668-680. PubMed ID: 28068087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive binding of a benzimidazole to the histone-binding pocket of the Pygo PHD finger.
    Miller TC; Rutherford TJ; Birchall K; Chugh J; Fiedler M; Bienz M
    ACS Chem Biol; 2014 Dec; 9(12):2864-74. PubMed ID: 25323450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Privileged diazepine compounds and their emergence as bromodomain inhibitors.
    Smith SG; Sanchez R; Zhou MM
    Chem Biol; 2014 May; 21(5):573-83. PubMed ID: 24746559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
    Raj U; Kumar H; Varadwaj PK
    J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.
    Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH
    J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
    Fong KW; Zhao JC; Song B; Zheng B; Yu J
    Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit.
    Gerstenberger BS; Trzupek JD; Tallant C; Fedorov O; Filippakopoulos P; Brennan PE; Fedele V; Martin S; Picaud S; Rogers C; Parikh M; Taylor A; Samas B; O'Mahony A; Berg E; Pallares G; Torrey AD; Treiber DK; Samardjiev IJ; Nasipak BT; Padilla-Benavides T; Wu Q; Imbalzano AN; Nickerson JA; Bunnage ME; Müller S; Knapp S; Owen DR
    J Med Chem; 2016 May; 59(10):4800-11. PubMed ID: 27115555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.